Skip to main content

and
  1. Article

    Open Access

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

    The East Asia S-1 Trial in Lung Cancer (EAST-LC) was a randomized phase III study conducted in East Asia that demonstrated the non-inferiority of S-1 to docetaxel in previously treated patients with advanced n...

    Shunichi Sugawara, Kazuhiko Nakagawa in International Journal of Clinical Oncology (2019)

  2. Article

    Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

    Noboru Yamamoto, Koichi Goto, Makoto Nishio in International Journal of Clinical Oncology (2017)

  3. Article

    Open Access

    Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

    In Japan, the clinical efficacy of erlotinib monotherapy in epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer was demonstrated in the phase II JO22903 trial, which reported a me...

    Noboru Yamamoto, Koichi Goto, Makoto Nishio in International Journal of Clinical Oncology (2017)

  4. Article

    Open Access

    Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib

    Lenvatinib (E7080), an oral multi-kinase inhibitor, has inhibitory action on tumor cell proliferation and tumor angiogenesis in preclinical models. We evaluated correlations between pharmacodynamic (PD) biomar...

    Noriyuki Koyama, Kenichi Saito, Yuki Nishioka, Wataru Yusa, Noboru Yamamoto in BMC Cancer (2014)

  5. Article

    Open Access

    Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

    Metastasis is a common event and the main cause of death in cancer patients. Lymphangiogenesis refers to the formation of new lymphatic vessels and is thought to be involved in the development of metastasis. S...

    Yasuo Kodera, Yasufumi Katanasaka, Yuka Kitamura, Hitoshi Tsuda in Breast Cancer Research (2011)

  6. No Access

    Article

    Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors

    Panitumumab is a fully human, monoclonal antibody against the epidermal growth factor receptor. Previous studies in non-Japanese patients with solid tumors showed that panitumumab exhibited nonlinear pharmacok...

    Toshihiko Doi, Atsushi Ohtsu, Makoto Tahara in International Journal of Clinical Oncology (2009)

  7. No Access

    Article

    A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer

    We aimed to identify, through a review of the literature, candidate genes for a prospective predictive chemosensitivity test in patients with breast cancer.

    Ikuo Sekine, Chikako Shimizu, Kazuto Nishio in International Journal of Clinical Oncology (2009)

  8. No Access

    Article

    Translational and clinical studies of target-based cancer therapy

    The increasing number of negative trials in cancer treatment has prompted a systematic re-evaluation of target-based drugs. It is our impression that the sensitivity of current clinical trial methodology is in...

    Nagahiro Saijo, Kazuto Nishio in International Journal of Clinical Oncology (2003)